Similar articles

• [Pharmacological studies on 2-methyl-4-amino-6-methoxy-s-triazine (CV399); with special reference to its central effects].

  Chiba S, Nagawa Y, Yui T. Chiba S, et al. Nihon Yakurigaku Zasshi. 1970;66(1):64-75. Nihon Yakurigaku Zasshi. 1970. PMID: 4393359 Japanese. No abstract available.
• Possible loci of action of 2-ethyl-4-ethylamino-6-methoxy-s-triazine for electroencephalographic and sympathetic activation in cat.

  Saji Y, Chiba S, Takeo Y, Yui T. Saji Y, et al. Arzneimittelforschung. 1970 Oct;20(10):1591-4. Arzneimittelforschung. 1970. PMID: 4320400 No abstract available.
• [Pharmacological properties of the new neuroleptic of the phenothiazine series--dixyrazine].

  Mikhaĭlova TV, Terekhina AI, Gilev AP. Mikhaĭlova TV, et al. Farmakol Toksikol. 1969 Jan-Feb;32(1):28-31. Farmakol Toksikol. 1969. PMID: 4388895 Russian. No abstract available.
• [Pharmacological, pharmacokinetic and toxicological research on mesoridazine (NC 123)].

  Loew DM, Grauwiler J, Griffith R, Taeschler M, Weidmann H, Zehnder K. Loew DM, et al. Boll Chim Farm. 1967 May;106(5):332-71. Boll Chim Farm. 1967. PMID: 4890002 Review. Italian. No abstract available.
• Pharmacology of the central nervous system.

  Norton S, Walaszek EJ. Norton S, et al. Prog Neurol Psychiatry. 1967;22:121-45. doi: 10.1016/b978-1-4831-9662-6.50009-3. Prog Neurol Psychiatry. 1967. PMID: 4972194 Review. No abstract available.